88IV - PR Newswire Asia's news - Medical/Pharmaceuticals

< Previous page

| Title only | Print

Next page >

Mabwell's CDH17-targeting ADC 7MW4911 Receives IND Clearance from FDA SHANGHAI , Aug. 19, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its self-developed CDH17-targeting ADC (R&D code: ... 2025-08-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
LabConnect Launches LabConnector™ to Streamline Lab Data Integration New service ensures faster, more accurate data delivery to clients ... 2025-08-19T Computer/Electronics Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
WuXi Biologics Reports Solid 2025 Interim Results Revenue increased by 16.1% YoY to RMB 9,953.2 million ; revenue growth from continuing operations was 20.2% IFRS Gross profit margin expanded by 3.6% YoY to 42.7% EBITDA grew 50.5% YoY ... 2025-08-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Nature Medicine Publishes Results of Phase II Study of Sacituzumab Tirumotecan Plus Tagitanlimab as First-Line Therapy for NSCLC CHENGDU, China , Aug. 19, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990) announced that clinical data from a Phase II study evaluating ... 2025-08-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Nilesh Shah joins Illumina as Head of Region, AMEA SINGAPORE , Aug. 19, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the appointment of Nilesh Shah as Head of ... 2025-08-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Antengene's ATG-022 (CLDN18.2 ADC) Granted Breakthrough Therapy Designation for the Treatment of Gastric/Gastroesophageal Junction Adenocarcinoma SHANGHAI and HONG KONG , Aug. 19, 2025 /PRNewswire/ -- Antengene Corporation Limited ( "Antengene" , SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated ... 2025-08-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Tigermed Receives MSCI ESG AAA Rating HANGZHOU, China , Aug. 19, 2025 /PRNewswire/ -- Tigermed is proud to announce that it has been awarded an MSCI Environmental, Social, and Governance (ESG) Rating of AAA, the highest rating in the ... 2025-08-19T Health Care/Hospital Medical/Pharmaceuticals
Beyfortus® (nirsevimab) approved in Singapore to protect all infants against RSV disease Beyfortus (nirsevimab) is the only option that can offer RSV protection designed for all infants with proven high, sustained efficacy, favourable safety and public health impact demonstrated in the real ... 2025-08-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries YANTAI, China, Aug. 19, 2025 /PRNewswire/ -- RemeGen Co., Ltd. (Stock Code: 688331.SH/09995.HK, "RemeGen"), a leading Chinese biopharmaceutical company, announced today that it has entered ... 2025-08-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
openRxiv names Dr. Tracy Teal first CEO to advance open science Scientist and nonprofit leader who previously led The Carpentries and Dryad to lead the organization that oversees bioRxiv and medRxiv. ... 2025-08-19T Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2025

Suntek Computer Systems Limited.

All rights reserved